CNBC's Meg Tirrell breaks down factors from the worst flu season since 2010 and the effectiveness of the current flu shot.
Some states are reporting a higher number of deaths from flu this year than usual. CNBC's Meg Tirrell takes a look at how the medical community is dealing with the outbreak.
Johnson & Johnson CEO Alex Gorsky, a grandson of immigrants, talked to Meg Tirrell about the importance of the Dream Act to the company, which recently joined the Coalition for the American Dream in support of DACA recipients.
CNBC's Meg Tirrell speaks with Leonard Schleifer, Regeneron CEO, about how the company will benefit from tax cuts, as well as pricing competition among drug companies.
CNBC's Meg Tirrell speaks with Verily Chief Medical Officer Dr. Jessica Mega about the role Alphabet plays in the biotech company and what it could mean for the future of medicine.
Gilead CEO John Milligan speaks to CNBC's Meg Tirrell at the J.P. Morgan Health Care Conference about the company's M&A outlook, drug pricing and their work on cancer and Hepatitis C treatments.
At the J.P. Morgan Health Care Conference, Valeant CEO Joe Papa speaks with CNBC's Meg Tirrell about the turnaround in the company and their drug pricing strategy.
At the J.P. Morgan Health Care Conference, Johnson & Johnson CEO Alex Gorsky speaks with CNBC's Meg Tirrell about the impact of tax reform, his outlook for M&A in different business segments and competition with Amazon potentially in pharmaceuticals.
CNBC's Meg Tirrell reports details on the biggest health-care investing event of the year.
CNBC's Meg Tirrell speaks with Merck CEO Ken Frazier about the impact that tax reform will have on the company and the company's overall performance.